Mode
Text Size
Log in / Sign up
Phase 4 N=3 Treatment

Mobility Training Using a Bionic Knee Orthosis in Patients Chronic Post-Stroke: A Case Series

Stroke

Enrolled (actual)
3
Serious AEs
0.0%
Results posted
Aug 2013
Primary outcome: Primary: Ambulation Speed — 0.60; 0.29; 0.83; 0.81 meters per second (m/s)

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Tibion Bionic Leg (Device)
Age
Adult · 40+ yrs
Sex
All
Sponsor
Tibion Bionics, Inc.
Primary completion
Dec 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Ambulation Speed
0.60; 0.29; 0.83; 0.81; 0.43; 1.03
SECONDARY
6 Minute Walk Test (6 MWT)
170; 93; 271; 207; 140; 300
SECONDARY
Timed Up and Go (TUG) Test
21.4; 21.4; 9.14; 14.5; 23.3; 8.94
SECONDARY
Five Times Sit to Stand Test (5 x STS)
12.1; 12.4; 11.4; 10.5; 13.0; 12.2
SECONDARY
Step Length
0.49; 0.29; 0.54; 0.56; 0.40; 0.59

Summary

This pilot study examined the effect of task-oriented mobility training in three persons chronic post-stroke using a novel, wearable, mobile intention-based robotic orthosis (Tibion Bionic Leg).

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • Aged 40 to 60 years
  • One year status post-stroke
  • Able to walk at least 10 meters
  • Independence in self-care

Exclusion Criteria

  • Medically unstable
  • Major cardiopulmonary deficiency
  • Major depression
  • Significant cognitive deficit
  • Currently receiving gait training
  • Younger than 40 years of age
  • Older than 60 years of age
  • Unable to walk at least 10 meters
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01499862). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search